ODX.L Regulatory News (ODX)

30 June 2011 AIM: ODX

Omega Diagnostics Group PLC

("Omega" or "the Company")

Directorate Change

Omega, the AIM listed medical diagnostics company, announces that Jag Grewal will join the Board as an Executive Director with immediate effect.

Jag Grewal, aged 42, joined the Company on 6 June 2011 as Group Sales and Marketing Director. Jag has worked in diagnostics for over 20 years having started out as a Clinical Biochemist in the NHS. In 1995, he joined Beckman Instruments where he developed a career spanning 15 years in sales and marketing holding a variety of positions in sales, product management and marketing management.

In 2009, Jag left as Northern Europe Marketing Manager to join Serco Health where he helped create the first joint venture within UK pathology between Serco Health and Guys and St Thomas' Hospital NHS Foundation Trust. Jag is also past Chairman and current treasurer of the British In-Vitro Diagnostics Association (BIVDA).

Andrew Shepherd, the Company's Chief Executive said: "We are very pleased to welcome Jag to the Board and his wealth of experience will be beneficial as we expand the scale of the Group's sales and marketing function in line with our expansion plans."

For further enquiries please contact:

Additional information:

Jag Grewal, aged 42, holds no shares in the Company and other than as set out below, there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Grewal's appointment today as a Director of the Company.

Mr Grewal is a director / partner or has been a director / partner of the following companies / partnerships during the previous five years:

British In-Vitro Diagnostics Association